Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Email me when HR 9699 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HR 9699. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill forces the Department of Health and Human Services to publish contracts and communications about drug pricing agreements that reference foreign prices or other special terms. It applies to deals with major manufacturers made after Jan. 20, 2025 and any new deals thereafter. The goal is to increase transparency so policymakers and the public can see how drug prices are set and assess their impact on Medicare, Medicaid and consumers.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HR 9699
3 free questions a day, no accountSponsors
- Rep. Chu, Judy [D-CA-28] (D) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HR 9699 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HR 9699 freeOr ask your AI assistant about HR 9699 directly:
Add to Claude, ChatGPT or Cursor